Edition:
United States

Biomerieux SA (BIOX.PA)

BIOX.PA on Paris Stock Exchange

69.90EUR
22 Sep 2017
Change (% chg)

€-0.13 (-0.19%)
Prev Close
€70.03
Open
€69.76
Day's High
€70.22
Day's Low
€69.01
Volume
84,157
Avg. Vol
102,235
52-wk High
€72.00
52-wk Low
€42.68

Chart for

About

Biomerieux SA is a France-based company that specializes in the field of in-vitro diagnostics for medical and industrial applications. The Company designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial... (more)

Overall

Beta: 0.37
Market Cap(Mil.): €8,273.45
Shares Outstanding(Mil.): 118.36
Dividend: 0.33
Yield (%): 0.48

Financials

  Industry Sector
P/E (TTM): -- 31.44 16.08
EPS (TTM): -- -- --
ROI: -- 13.78 14.60
ROE: -- 16.62 14.03

European stocks bounce back as strong earnings in focus

LONDON Investors piled back into European stocks on Wednesday, boosting indexes higher in a rally a day after geopolitical concern caused a drop across equity markets.

Aug 30 2017

UPDATE 2-European stocks bounce back as strong earnings in focus

* Second quarter earnings to grow 16 pct - TR (Adds closing prices)

Aug 30 2017

European stocks bounce back as strong earnings in focus

LONDON, Aug 30 Investors piled back into European stocks on Wednesday, boosting indexes higher in a relief rally after geopolitical concerns caused a sharp dip across equity markets.

Aug 30 2017

BRIEF-Biomerieux H1 operating income rises to 163 million euros

* IS NOW TARGETING ORGANIC SALES GROWTH FOR FULL YEAR OF BETWEEN 9 PCT AND 10 PCT

Aug 30 2017

BRIEF-Bim Q2 net profit rises 50% to 216.4 mln lira, revises 2017 revenue growth outlook to 20-23%

* REPORTED ON MONDAY Q2 REVENUE OF 6.21 BILLION LIRA VERSUS 4.91 BILLION LIRA YEAR AGO

Aug 15 2017

BRIEF-Biomérieux receives FDA clearance for expanded pathogen identification capability on VITEK® MS

* BIOMÉRIEUX RECEIVES FDA CLEARANCE FOR EXPANDED PATHOGEN IDENTIFICATION CAPABILITY ON VITEK® MS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Jul 31 2017

BRIEF-Sysmex and Biomérieux agreed to dissolve JV Sysmex Biomérieux co., ltd.

* SYSMEX AND BIOMÉRIEUX AGREED TO DISSOLVE THE JOINT VENTURE SYSMEX BIOMÉRIEUX CO., LTD.

Jul 27 2017

Veneto Banca says has started process to sell stake in BIM

MILAN Veneto Banca, one of two troubled regional lenders Italy is winding down, said on Thursday it had started the process to sell its controlling stake in private banking group BIM .

Jul 06 2017

Veneto Banca says has started process to sell stake in BIM

MILAN, July 6 Veneto Banca, one of two troubled regional lenders Italy is winding down, said on Thursday it had started the process to sell its controlling stake in private banking group BIM.

Jul 06 2017

Italy's BIM head confident the unit can be sold fast after Veneto Banca liquidation

MILAN The head of Italy's BIM said on Monday he was confident the private banking group would be sold on the market quickly following the decision to liquidate its main shareholder Veneto Banca.

Jun 26 2017

Earnings vs. Estimates